Wednesday , November 22 2017

Safety

Safety and Error Prevention: Diabetes in Control is committed to error prevention, safety know-how, awareness of lessons learned, voluntary error reporting, and patient compliance. Working in partnership with the Institute for Safe Medication Practice Also, our popular Disasters Averted section will give you more ideas on safety and preventing errors.

Clinical Trial Examines Safety, Effectiveness of Drug to Treat Binge Eating Disorder

Lisdexamfetamine dimesylate, used to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients… At some doses, the medication lisdexamfetamine dimesylate, a drug approved to treat attention-deficit/hyperactivity disorder, was effective compared with placebo in decreasing binge-eating (BE) days in patients with binge-eating disorder (BED), a …

Read More »

“Do Not Crush, Chew or Cut”

DCMS194DDA

From the Institute for Safe Medication Practices (ISMP): When a patient is prescribed a timed release medication such as Glucotrol XL or Glucophage XR, clinicians need to ensure that the patients understand that they should not crush, chew or cut these pills. The medications must be swallowed whole.  In one case …

Read More »